Somalutine Depot (Lanreotide) Copay Assistance Coming Soon

Is Somatuline Depot (lanreotide) copay assistance free for patients?

Yes, copay assistance programs for Somatuline Depot (lanreotide) are typically free to apply for. Manufacturer copay cards, patient assistance programs, and foundation grants do not charge application fees. Patients apply through their dispensing specialty pharmacy or directly with the program sponsor.

What copay assistance typically includes at no cost:

• Manufacturer copay card applications for Somatuline Depot (lanreotide)
• Insurance verification and benefit checks
• Prior authorization support
• Foundation grant applications for acromegaly and neuroendocrine tumor treatment
• Ongoing benefit monitoring and annual renewals

Somatuline Depot (lanreotide) savings programs available:

For patients with commercial insurance, manufacturer copay cards for Somatuline Depot can significantly reduce out-of-pocket costs.

For Medicare and Medicaid patients, foundation-based assistance programs provide grants that help cover medication expenses. These programs are typically free to apply for.

For uninsured patients, manufacturer patient assistance programs may provide Somatuline Depot (lanreotide) at no cost or significantly reduced prices based on financial need.

Please note: QuickRx Specialty Pharmacy does not currently dispense Somatuline Depot (lanreotide). This medication is available through limited distribution specialty pharmacy networks.

Who qualifies for Somatuline Depot (lanreotide) copay assistance?

Eligibility for Somatuline Depot (lanreotide) copay assistance depends on the patient’s insurance type and financial situation. Different programs serve different patient populations.

Eligibility for Somatuline Depot manufacturer copay cards:

Patients with commercial insurance may qualify for manufacturer copay cards. Typical requirements include:

• Active commercial (private) health insurance that covers Somatuline Depot
• Valid prescription for lanreotide
• Treatment for FDA-approved indications (acromegaly, GEP-NETs, or carcinoid syndrome)
• US residency

Alternative assistance for other insurance types:

Medicare and Medicaid patients cannot use manufacturer copay cards due to federal regulations, but may qualify for foundation grants and patient assistance programs specifically designed for government insurance beneficiaries.

Uninsured patients may qualify for manufacturer patient assistance programs that provide free or low-cost Somatuline Depot (lanreotide) based on household income and financial need.

How patients typically access these programs:

Most Somatuline Depot (lanreotide) copay assistance programs are coordinated through the patient’s dispensing specialty pharmacy, which verifies insurance, identifies eligible programs, and submits applications on the patient’s behalf.

Please note: QuickRx Specialty Pharmacy does not currently dispense Somatuline Depot (lanreotide).

How much do patients typically save with Somatuline Depot (lanreotide) copay assistance?

Savings amounts vary by insurance type, program benefit limits, and individual circumstances. Multiple assistance programs can sometimes be layered to maximize savings.

Potential Somatuline Depot (lanreotide) copay assistance savings:

With commercial insurance, manufacturer copay cards can significantly reduce out-of-pocket costs for Somatuline Depot. Savings depend on the insurance plan’s copay or coinsurance amount and specific program benefit limits.

With Medicare or Medicaid, foundation grants and patient assistance programs help cover medication costs that government insurance plans don’t pay. Grant amounts vary by foundation and availability of funds.

For uninsured patients, manufacturer patient assistance programs may provide Somatuline Depot (lanreotide) at no cost for patients who meet income eligibility requirements.

Why savings amounts vary:

The cost of Somatuline Depot (lanreotide) can be substantial without assistance. Actual savings depend on:

• The patient’s insurance plan coverage and cost-sharing structure
• Specialty pharmacy dispensing requirements
• Annual benefit caps on copay assistance programs
• Foundation funding availability at the time of application
• Household income (for patient assistance programs)

Please note: QuickRx Specialty Pharmacy does not currently dispense Somatuline Depot (lanreotide).

Can Medicare patients access Somatuline Depot (lanreotide) financial assistance?

Yes, Medicare patients can access Somatuline Depot (lanreotide) financial assistance, but not through manufacturer copay cards. Medicare beneficiaries may qualify for foundation grants and other patient assistance programs specifically designed to help cover out-of-pocket costs for neuroendocrine medications.

Why Medicare patients cannot use copay cards:

Federal anti-kickback laws prohibit pharmaceutical manufacturers from offering copay cards to Medicare and Medicaid beneficiaries. This applies to Somatuline Depot (lanreotide) and all other prescription medications.

Alternative assistance for Medicare patients:

Medicare patients with a Somatuline Depot (lanreotide) prescription may qualify for:

• Independent charitable foundations that provide grants for neuroendocrine medications
• Disease-specific foundations focused on acromegaly and NETs
• Manufacturer patient assistance programs (for qualifying patients)
• State pharmaceutical assistance programs (SPAPs) where available
• Medicare Extra Help / Low-Income Subsidy programs

How Medicare Part D and Part B coverage typically works:

Somatuline Depot is generally covered under Medicare Part B (for injections administered in a healthcare setting) or Medicare Part D, depending on the administration setting. Coverage details and cost-sharing vary by plan.

Please note: QuickRx Specialty Pharmacy does not currently dispense Somatuline Depot (lanreotide).

What options are available if a patient cannot afford Somatuline Depot (lanreotide)?

Patients who cannot afford Somatuline Depot (lanreotide) have several financial assistance options available depending on their insurance status. These programs are designed to help patients access necessary treatment for acromegaly, neuroendocrine tumors, and carcinoid syndrome.

Financial assistance options by insurance type:

With commercial insurance:

• Manufacturer copay cards for Somatuline Depot
• Disease-specific foundation grants for acromegaly and NETs
• Premium assistance programs to help with insurance costs

With Medicare or Medicaid:

• Independent charitable foundation grants
• State pharmaceutical assistance programs (SPAPs)
• Manufacturer patient assistance programs (if eligible)
• Medicare Extra Help / Low-Income Subsidy programs

Without insurance:

• Manufacturer patient assistance programs providing free medication
• Foundation grants for uninsured patients
• Hospital charity care programs

How patients typically access these programs:

Most Somatuline Depot (lanreotide) financial assistance is coordinated through the patient’s dispensing specialty pharmacy. Patients may also contact program sponsors directly or work with patient navigators at their treating physician’s office.

Please note: QuickRx Specialty Pharmacy does not currently dispense Somatuline Depot (lanreotide). This medication is available through limited distribution specialty pharmacy networks. We are working to expand our specialty medication offerings.

What is Somatuline Depot (lanreotide) used for?

Somatuline Depot (lanreotide) is a prescription medication used to treat three specific conditions: acromegaly, gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and carcinoid syndrome. It is a long-acting somatostatin analog given as an injection.

Acromegaly treatment:

Somatuline Depot is used to treat acromegaly, a condition where the body produces too much growth hormone, typically due to a pituitary tumor. Excess growth hormone causes:

• Abnormal growth of bones and tissues, especially in the hands, feet, and face
• Joint pain and limited mobility
• Cardiovascular problems
• Metabolic changes including diabetes

Lanreotide works by reducing growth hormone levels in patients with acromegaly, helping to control symptoms and prevent complications.

Neuroendocrine tumor (NET) treatment:

Somatuline Depot is used to treat gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which are rare tumors that develop in the digestive system or pancreas. These tumors can produce hormones that cause various symptoms.

For GEP-NETs, lanreotide helps slow tumor growth and control hormone-related symptoms.

Carcinoid syndrome treatment:

Somatuline Depot is used to treat carcinoid syndrome, a group of symptoms caused by hormone-secreting neuroendocrine tumors. Symptoms of carcinoid syndrome include:

• Flushing (sudden redness and warmth of the face and upper body)
• Diarrhea
• Wheezing or difficulty breathing
• Rapid heartbeat

Lanreotide helps control these symptoms by reducing hormone secretion from the tumors.

How Somatuline Depot works:

Lanreotide is a synthetic version of somatostatin, a natural hormone that regulates other hormones in the body. By mimicking somatostatin, Somatuline Depot:

• Reduces growth hormone production in acromegaly
• Slows tumor cell growth in neuroendocrine tumors
• Decreases hormone secretion from NETs that cause carcinoid syndrome

Long-acting formulation:

Somatuline Depot is designed as a long-acting injection, typically given once every 4 weeks. The “Depot” formulation slowly releases lanreotide over time, providing continuous treatment between injections.

Patients with questions about whether Somatuline Depot is right for their condition should speak with their endocrinologist or oncologist.

How is Somatuline Depot (lanreotide) given?

Somatuline Depot (lanreotide) is given as an injection into the fatty part of the skin (subcutaneous injection), typically in the upper outer area of the buttock. The injection is usually administered by a healthcare provider in a medical office or clinic.

Injection frequency:

Somatuline Depot is typically given once every 4 weeks (28 days). The long-acting formulation slowly releases lanreotide over time, so daily injections are not needed. The exact dosing schedule is determined by the prescribing physician based on the patient’s condition and response to treatment.

Where the injection is given:

The medication is injected deep into the fatty tissue under the skin, usually in the upper outer area of the buttock. Healthcare providers alternate between the left and right sides with each injection to reduce irritation at injection sites.

Who administers the injection:

Somatuline Depot is typically administered by a healthcare professional such as:

• A doctor or nurse in a medical office
• A trained nurse at an infusion center
• A home health nurse if home administration is arranged

In some cases, patients or caregivers may be trained to give the injection at home, but this requires proper instruction from healthcare providers.

What to expect during injection:

The injection process takes only a few minutes. Patients may experience:

• Brief discomfort or stinging when the needle enters the skin
• Mild irritation at the injection site afterward
• Temporary redness or soreness that typically resolves within a few days

Storage requirements:

If Somatuline Depot needs to be stored at home before injection, the prescribing physician, nurse, or pharmacist will provide specific storage instructions. Proper storage is important to maintain medication effectiveness.

Missed injection guidance:

If a scheduled Somatuline Depot injection is missed, the patient should contact their doctor for guidance. Maintaining the regular injection schedule is important for optimal treatment results.

What are common side effects of Somatuline Depot (lanreotide)?

Like all medications, Somatuline Depot (lanreotide) can cause side effects. Many patients experience only minor effects that improve over time. Patients should contact their doctor if side effects are bothersome or persistent.

Common side effects (minor):

• Gas
• Constipation, diarrhea, stomach pain, upset stomach, or nausea/vomiting
• Headache
• Dizziness
• Muscle or joint pain
• Muscle spasms
• Weight loss
• Irritation where the injection is given

Serious side effects requiring immediate medical attention:

Patients should call their doctor or get medical help right away if they experience:

Signs of allergic reaction:

• Rash, hives, itching
• Swollen, blistered, or peeling skin with or without fever
• Wheezing or chest tightness
• Trouble breathing, swallowing, or talking
• Swelling of mouth, face, lips, tongue, or throat

Signs of gallbladder problems:

• Pain in upper right belly area, right shoulder, or between shoulder blades
• Yellow skin or eyes (jaundice)
• Fever with chills
• Bloating or severe nausea/vomiting

Signs of pancreatitis (pancreas inflammation):

• Very severe stomach pain
• Very severe back pain
• Severe nausea or vomiting

Signs of high blood pressure:

• Very severe headache or dizziness
• Passing out
• Changes in eyesight

Signs of thyroid problems:

• Unexplained weight changes
• Feeling nervous, restless, or weak
• Hair thinning or depression
• Eye or neck swelling
• Trouble focusing or sensitivity to temperature
• Menstrual changes or shakiness

Cardiovascular symptoms:

• Chest pain or pressure
• Slow heartbeat
• Shortness of breath
• Flushing

Signs of high or low blood sugar:

• Breath that smells fruity
• Fast breathing or heartbeat
• Feeling confused, sleepy, or weak
• Flushing or unusual thirst/hunger
• Urinating more often than usual
• Shaking or sweating

Important health monitoring:

While taking Somatuline Depot, doctors typically monitor:

• Blood sugar levels (both high and low blood sugar can occur)
• Blood pressure
• Thyroid function
• Gallbladder health
• Heart rate and rhythm

This information is for educational purposes only and does not replace medical advice. Patients should discuss any side effects with their healthcare provider.

What should patients tell their doctor before starting Somatuline Depot (lanreotide)?

Before starting Somatuline Depot (lanreotide), patients should have an honest conversation with their doctor about complete medical history and all current medications. This helps prevent dangerous drug interactions and complications.

Tell the doctor about:

• Allergies to lanreotide or any part of Somatuline Depot
• Allergies to any other drugs, foods, or substances
• Pregnancy, planned pregnancy, or breastfeeding (patients must not breastfeed while taking Somatuline Depot or for 6 months after the last injection)
• Diabetes or blood sugar problems
• Heart problems or slow heart rate
• Thyroid problems
• Gallbladder disease or gallstones
• Liver or kidney problems
• History of pancreatitis

Provide a complete medication list:

Patients should tell their doctor and pharmacist about ALL medications they take, including:

• Prescription medications
• Over-the-counter (OTC) drugs
• Natural products and supplements
• Vitamins and herbal remedies

Somatuline Depot may interact with other drugs, so this information is needed to check for potential interactions.

Important drug interactions:

Patients should be especially sure to mention if they are taking:

• Diabetes medications (insulin or oral diabetes drugs)
• Blood pressure medications
• Heart medications
• Thyroid medications
• Other hormone medications

Fertility considerations:

Somatuline Depot may cause fertility problems that could affect the ability to have children. Patients planning to have children should discuss this with their doctor.

Questions patients may want to ask:

Before starting Somatuline Depot, patients may want to understand:

• Why lanreotide was chosen for the specific condition
• How often injections will be needed
• What side effects to watch for and when to call for help
• How to monitor blood sugar if diabetic
• When to schedule follow-up appointments and lab work
• What symptoms indicate calling the doctor immediately
• How to access copay assistance to afford the medication

What precautions should patients take while using Somatuline Depot (lanreotide)?

Somatuline Depot (lanreotide) requires careful management to ensure safe and effective treatment. The following precautions are typically recommended during treatment.

Dizziness precautions:

Somatuline Depot may cause dizziness:

• Avoid driving or operating machinery when feeling dizzy
• Don’t perform tasks requiring alertness until familiar with how the medication affects you
• Talk with a doctor if dizziness persists or worsens

Blood sugar monitoring:

Both high and low blood sugar can occur with Somatuline Depot:

• Check blood sugar regularly as directed by the doctor
• Be alert for symptoms of high blood sugar (increased thirst, urination, fruity breath odor)
• Watch for signs of low blood sugar (shakiness, sweating, confusion, rapid heartbeat)
• Patients with diabetes may need diabetes medication adjustments
• Keep fast-acting sugar sources available in case of low blood sugar

Blood pressure monitoring:

High blood pressure can occur with Somatuline Depot:

• Have blood pressure checked regularly as directed
• Report severe headaches, dizziness, or vision changes immediately
• Blood pressure medication may need adjustment

Regular blood work and monitoring:

Doctors typically order regular tests to monitor:

• Thyroid function (TSH and thyroid hormones)
• Blood glucose levels
• Growth hormone and IGF-1 levels (for acromegaly patients)
• Liver function
• Gallbladder health (imaging studies if needed)
• Heart function (ECG to check heart rate and rhythm)

Gallbladder awareness:

Gallbladder problems including gallstones can develop with Somatuline Depot use:

• Report severe abdominal pain immediately, especially in the upper right area
• Watch for yellowing of skin or eyes (jaundice)
• Notify the doctor of nausea, vomiting, or fever
• Some patients may require gallbladder removal if serious problems develop

Inform all healthcare providers:

Patients should inform all doctors, nurses, pharmacists, dentists, and other healthcare providers that they receive Somatuline Depot injections. This is especially important before any surgeries, dental work, or other medical procedures.

Pregnancy and breastfeeding precautions:

For pregnancy or planned pregnancy:

• Discuss risks and benefits with the doctor
• Use effective contraception if pregnancy should be avoided
• Tell the doctor immediately if pregnancy occurs

For breastfeeding:

• Do not breastfeed while receiving Somatuline Depot
• Do not breastfeed for 6 months after the last injection

What is acromegaly?

Acromegaly is one of the conditions that Somatuline Depot (lanreotide) is used to treat. Understanding acromegaly helps patients better manage their treatment and recognize the importance of medication adherence.

What happens in acromegaly:

Acromegaly is a rare hormonal disorder that occurs when the pituitary gland produces too much growth hormone, usually due to a benign tumor (adenoma) on the pituitary gland. This excess growth hormone causes:

• Abnormal growth of bones and soft tissues
• Progressive changes in physical appearance
• Serious health complications if left untreated

Common symptoms and signs of acromegaly:

Physical changes:

• Enlarged hands and feet (rings and shoes no longer fit)
• Facial features become coarser (enlarged nose, lips, jaw)
• Protruding brow and lower jaw
• Widely spaced teeth
• Enlarged tongue
• Deepening of the voice
• Skin changes (thickening, increased oiliness, skin tags)
• Excessive sweating and body odor

Joint and muscle symptoms:

• Joint pain and limited range of motion
• Arthritis
• Carpal tunnel syndrome
• Muscle weakness and fatigue

Other health problems:

• Headaches (from pituitary tumor pressure)
• Vision problems (if tumor presses on optic nerves)
• High blood pressure
• Diabetes or prediabetes
• Heart disease and enlarged heart
• Sleep apnea
• Colon polyps (increased cancer risk)
• Menstrual irregularities in women
• Erectile dysfunction in men

Why acromegaly develops slowly:

Acromegaly typically develops gradually over many years, which is why it’s often not diagnosed immediately. The slow progression means physical changes may not be noticed until they become significant. Average time from symptom onset to diagnosis is about 5-10 years.

How Somatuline Depot helps acromegaly:

Somatuline Depot (lanreotide) treats acromegaly by:

• Reducing growth hormone production
• Lowering IGF-1 levels (a hormone produced in response to growth hormone)
• Shrinking the pituitary tumor in some patients
• Preventing progression of physical changes
• Reducing symptoms like headaches, sweating, and joint pain
• Helping prevent serious complications

Other acromegaly treatments:

Treatment for acromegaly may include:

• Surgery to remove the pituitary tumor (often first-line treatment)
• Medications like Somatuline Depot (used after surgery or when surgery isn’t possible)
• Radiation therapy in some cases
• Combination therapy for optimal control

Importance of ongoing monitoring:

Even after successful treatment, acromegaly requires lifelong monitoring because:

• Tumors can recur after surgery
• Hormone levels need regular checking
• Complications require ongoing management
• Medication like Somatuline Depot may be needed long-term

What are neuroendocrine tumors (NETs)?

Neuroendocrine tumors (NETs) are one of the conditions that Somatuline Depot (lanreotide) is used to treat. Understanding NETs helps patients better manage their treatment.

What are neuroendocrine tumors:

Neuroendocrine tumors are rare tumors that develop from neuroendocrine cells, which are specialized cells throughout the body that have features of both nerve cells and hormone-producing cells. These tumors can occur in many locations, but Somatuline Depot specifically treats gastroenteropancreatic NETs (GEP-NETs), which develop in:

• The gastrointestinal (GI) tract (stomach, intestines, appendix, colon, rectum)
• The pancreas

Types of neuroendocrine tumors:

Functional NETs: Produce and release excess hormones that cause symptoms (like carcinoid syndrome)

Non-functional NETs: Don’t produce hormones or produce hormones that don’t cause symptoms, so they may not be discovered until they grow large or spread

Common symptoms of GEP-NETs:

Symptoms vary depending on tumor location and whether it produces hormones:

If tumor produces hormones (functional NET):

• Flushing (sudden redness and warmth of face and upper body)
• Diarrhea
• Wheezing or difficulty breathing
• Rapid heartbeat
• Low blood sugar (if insulin-producing)
• Stomach ulcers (if gastrin-producing)

If tumor is large or spreading (functional or non-functional):

• Abdominal pain or discomfort
• Intestinal blockage
• Bleeding from digestive tract
• Weight loss without trying
• Fatigue and weakness
• Jaundice (yellowing of skin/eyes)

How NETs are classified:

NETs are graded based on how quickly they’re growing:

• Low-grade (Grade 1): Slow-growing, less aggressive
• Intermediate-grade (Grade 2): Moderately growing
• High-grade (Grade 3): Fast-growing, more aggressive

Somatuline Depot is typically used for well-differentiated (Grade 1 or 2) NETs.

How Somatuline Depot helps NETs:

Somatuline Depot (lanreotide) treats GEP-NETs by:

• Slowing tumor growth and progression
• Controlling hormone-related symptoms (if functional NET)
• Improving quality of life
• Potentially extending progression-free survival

Other NET treatments:

Treatment for NETs may include:

• Surgery to remove tumors (if possible)
• Medications like Somatuline Depot
• Other targeted therapies
• Chemotherapy (for some high-grade tumors)
• Peptide receptor radionuclide therapy (PRRT)
• Liver-directed therapies if NETs have spread to the liver

Importance of ongoing monitoring:

NETs require regular monitoring through:

• Blood tests (including chromogranin A and hormone levels)
• Imaging studies (CT, MRI, or specialized scans)
• Symptom assessment
• Nutritional status evaluation

What is carcinoid syndrome?

Carcinoid syndrome is one of the conditions that Somatuline Depot (lanreotide) is used to treat. Understanding carcinoid syndrome helps patients recognize symptoms and the importance of treatment.

What is carcinoid syndrome:

Carcinoid syndrome is a group of symptoms caused by hormone-secreting neuroendocrine tumors (NETs), usually when these tumors have spread to the liver or when they originate in certain locations like the lungs. The tumors release excess hormones (primarily serotonin and other substances) into the bloodstream, causing various symptoms.

Common symptoms of carcinoid syndrome:

Flushing:

• Sudden redness and warmth of the face, neck, and upper chest
• Episodes can last from minutes to hours
• May be triggered by stress, alcohol, certain foods, or physical activity
• Skin may appear red or purple during episodes

Diarrhea:

• Frequent, watery bowel movements
• Can occur multiple times daily
• May be accompanied by abdominal cramping
• Can lead to dehydration and weight loss

Respiratory symptoms:

• Wheezing or difficulty breathing
• Asthma-like symptoms
• May worsen during flushing episodes

Cardiovascular symptoms:

• Rapid or irregular heartbeat
• Low or high blood pressure during episodes
• In advanced cases, damage to heart valves (carcinoid heart disease)

Other symptoms:

• Abdominal pain or bloating
• Nausea
• Skin changes (thickening, especially on legs)
• Joint pain
• Fatigue and weakness

What causes carcinoid syndrome:

Carcinoid syndrome typically occurs when:

• Neuroendocrine tumors in the digestive system spread (metastasize) to the liver
• Hormones from liver metastases enter the bloodstream directly
• Tumors originate in locations like the lungs where hormones bypass liver metabolism

The liver normally breaks down these hormones, which is why carcinoid syndrome usually only develops when tumors spread to the liver or originate outside the digestive system.

How Somatuline Depot helps carcinoid syndrome:

Somatuline Depot (lanreotide) treats carcinoid syndrome by:

• Reducing hormone secretion from neuroendocrine tumors
• Decreasing frequency and severity of flushing episodes
• Reducing diarrhea
• Controlling other hormone-related symptoms
• Improving quality of life
• Helping prevent carcinoid crisis (life-threatening complication)

Other treatments for carcinoid syndrome:

Management may include:

• Somatostatin analogs like Somatuline Depot (primary treatment)
• Antidiarrheal medications
• Nutritional support (vitamin supplementation, especially B vitamins)
• Avoiding triggers (alcohol, aged cheeses, certain medications)
• Treatment of underlying tumors (surgery, targeted therapies)

Carcinoid crisis prevention:

Carcinoid crisis is a life-threatening complication that can occur during:

• Surgery or anesthesia
• Severe stress
• Tumor manipulation

Patients with carcinoid syndrome should:

• Inform all healthcare providers about their condition
• Carry medical alert identification
• Receive preventive treatment before surgeries or procedures

Regular monitoring needed:

• Blood tests (5-HIAA urine test, chromogranin A)
• Imaging to monitor tumor growth
• Heart function tests (echocardiogram to check for valve damage)
• Symptom diaries to track flushing and diarrhea
• Nutritional assessments

Can patients drink alcohol while taking Somatuline Depot (lanreotide)?

Patients with carcinoid syndrome should generally avoid alcohol while taking Somatuline Depot (lanreotide). For patients with acromegaly or NETs without carcinoid syndrome, alcohol use should be discussed with the prescribing doctor.

Why carcinoid syndrome patients should avoid alcohol:

Alcohol is a common trigger for carcinoid syndrome symptoms:

• Can cause or worsen flushing episodes
• May increase severity and duration of flushing
• Can trigger or worsen diarrhea
• May exacerbate other hormone-related symptoms

Even while taking Somatuline Depot to control symptoms, alcohol can still trigger breakthrough symptoms in carcinoid syndrome patients.

Other foods and substances to avoid with carcinoid syndrome:

Patients with carcinoid syndrome should also avoid:

• Aged cheeses
• Smoked or cured meats
• Foods high in tyramine
• Certain medications (consult a pharmacist)
• Stressful situations when possible

For acromegaly patients:

For patients with acromegaly without carcinoid syndrome:

• Discuss alcohol consumption with the doctor
• Moderate alcohol use may be acceptable
• Consider that alcohol can affect blood sugar levels
• Be aware of potential interactions with other medications

General considerations about alcohol:

Keep in mind that alcohol can:

• Worsen dizziness (a potential side effect of Somatuline Depot)
• Affect blood sugar control (important since Somatuline can cause blood sugar changes)
• Interact with other medications
• Impair judgment if recognizing serious side effects is needed

Questions for your doctor:

• Is it safe to consume any alcohol given the specific condition?
• What symptoms should be monitored if alcohol is consumed?
• Are there other dietary restrictions to follow?
• How can personal symptom triggers be identified?

How should Somatuline Depot (lanreotide) be stored?

If Somatuline Depot (lanreotide) needs to be stored at home before an injection appointment, proper storage is essential to maintain medication effectiveness. The dispensing pharmacy and prescribing doctor provide specific storage instructions for each patient’s situation.

General storage guidelines:

Somatuline Depot typically requires refrigeration:

• Store in the refrigerator at the temperature specified on the packaging
• Keep in the original packaging to protect from light
• Do not freeze the medication
• Do not use if the medication has been frozen

Before injection:

Somatuline Depot should typically be brought to room temperature before injection:

• Remove from refrigerator before the appointment as directed
• Allow medication to warm naturally — do not heat or microwave
• The healthcare provider will prepare the medication properly

Transportation to appointments:

When transporting Somatuline Depot to a doctor’s office or infusion center:

• Keep medication refrigerated until departure
• Use an insulated cooler with ice packs for transport
• Protect from extreme temperatures
• Don’t leave in hot car or direct sunlight
• Bring directly to the appointment without other stops

What to check before use:

Before the medication is injected, healthcare providers should verify:

• The solution is clear and free of particles
• The medication hasn’t changed color
• The expiration date hasn’t passed
• The packaging is intact and undamaged

If anything looks wrong, the medication should not be used.

General medication safety:

• Keep all medications in a safe place away from children and pets
• Never use expired medication
• Don’t flush medication down toilet or pour down drain
• Ask a pharmacist about proper disposal methods
• Check for medication take-back programs in your area

Can pregnant or breastfeeding women take Somatuline Depot (lanreotide)?

Somatuline Depot (lanreotide) use during pregnancy and breastfeeding requires careful consideration and medical guidance. Risks and benefits should be discussed with the prescribing doctor.

Somatuline Depot during pregnancy:

Pregnant patients or those planning pregnancy should tell their doctor immediately. The doctor will weigh the potential benefits of Somatuline Depot treatment against possible risks to the developing baby.

Important pregnancy considerations:

• The effects of lanreotide on pregnancy are not fully understood
• Limited data is available about lanreotide use in pregnant women
• The doctor will consider the severity of the condition (acromegaly, NETs, or carcinoid syndrome)
• Stopping treatment suddenly may have consequences for the patient’s health
• More frequent monitoring may be needed if treatment continues during pregnancy

If pregnancy occurs while taking Somatuline Depot:

• Notify the doctor immediately
• Do not stop treatment without medical guidance
• The doctor will reassess the treatment plan
• Close monitoring will be necessary

Somatuline Depot while breastfeeding:

Patients should not breastfeed while receiving Somatuline Depot injections.

Important breastfeeding restrictions:

• Do not breastfeed while taking Somatuline Depot
• Do not breastfeed for 6 months after the last injection
• It is not known whether lanreotide passes into breast milk
• The potential risks to a nursing infant are unknown

Planning for breastfeeding:

• Patients considering breastfeeding should discuss this with their doctor before starting Somatuline Depot
• Consider alternative feeding options for the baby
• Explore whether alternative treatments are appropriate for the condition
• Understand the 6-month waiting period after stopping treatment

Fertility considerations:

Somatuline Depot may cause fertility problems in both men and women:

• This may affect the ability to have children
• Discuss fertility concerns with the doctor before starting treatment
• Ask about fertility preservation options if appropriate
• Consider timing of treatment when planning to have children

Birth control considerations:

Women of childbearing age should:

• Use effective contraception during treatment if pregnancy should be avoided
• Discuss birth control options with the doctor
• Consider that some conditions treated by Somatuline Depot may affect fertility
• Understand risks before conception

Men taking Somatuline Depot:

Male patients should discuss with their doctor:

• Potential effects on fertility
• Considerations if partner is pregnant or planning pregnancy
• Any concerns about fathering children during or after treatment

Medical References & Sources

REFERENCES TEXT:
The medical information about Somatuline Depot (lanreotide) on this page is for educational purposes only and is sourced from:

• U.S. Food and Drug Administration (FDA) approved prescribing information for Somatuline Depot (lanreotide injection)
• UpToDate clinical drug information database
• Peer-reviewed endocrinology and oncology medical literature
• Neuroendocrine Tumor Research Foundation resources
• Carcinoid Cancer Foundation educational materials

This information is not intended to replace professional medical advice from your doctor or healthcare provider. Always consult your endocrinologist, oncologist, or pharmacist for guidance about your specific Somatuline Depot treatment.

For questions about Somatuline Depot (lanreotide) copay assistance programs or financial help, contact QuickRx Specialty Pharmacy at (917) 830-2525

Last reviewed: November 2025